Tylophora is a vine that grows in hot climates. The leaves and root have been used to ease symptoms of asthma and seasonal allergies. Tylophora can be taken as a pill.


There are no advised doses for tylophora.

What Research Shows

Not Enough Data to Assess

  • Asthma/allergic rhinitis A1-A6

Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.

Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.

Safety Notes

It may be safe to take tylophora in small doses for a short time, but mouth pain, loss of taste, nausea, and vomiting may happen. Not enough studies have been done to say whether it is safe to use for a long period. It is also not known whether it is safe to take by women who are pregnant or breastfeeding.


Talk to your doctor about any supplements or therapy you would like to use. Some can interfere with treatment or make conditions worse such as:

  • People taking sedatives or pain medicine should talk to their doctor before taking tylophora. It may interact with the medicine.


REFA Asthma and Allergies

REFA1 Shivpuri DN, Menon MP, et al. A crossover double-blind study on Tylophora indica in the treatment for asthma and allergic rhinitis. J Allergy. 1969;43(3):145-150.

REFA2 Shivpuri DN, Singhal SC, et al. Treatment of asthma with an alcoholic extract of tylophora indica: a cross-over, double -blind study. Ann Allergy. 1972;30(7):407-412.

REFA3 Thiruvengadam KV, Haranath K, et al. Tylophora indica in bronchial asthma (a controlled comparison with a standard anti-asthmatic drug). J Indian Med Assoc. 1978 Oct 1;71(7):172-176.

REFA4 Gupta S, George P, et al. Tylophora indica in bronchial asthma--a double blind study. Indian J Med Res. 1979 Jun;69:981-989.

REFA5 Huntley A, Ernst E. Herbal medicines for asthma: a systematic review. Thorax. 2000 Nov;55(11):925-929.

REFA6 Clark CE, Arnold E, et al. Herbal interventions for chronic asthma in adults and children: a systematic review and meta analysis. Prim Care Respir J. 2010 Dec;19(4):307-314.

Revision Information

  • Reviewer: EBSCO NAT Review Board Eric Hurwitz, DC
  • Review Date: 07/2019
  • Update Date: 03/27/2020